Skip to main content

Table 6 Adverse effects

From: Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial

  Severity
Mild Moderate Severe
Adverse effects Number Number of patients (%) Number Number of patients (%) Number Number of patients (%)
All 3 2 (2.2) 0 0 (0.0) 0 0 (0.0)
Myocardial injury 1 1 (1.1) 0 0 (0.0) 0 0 (0.0)
 Angina 1 1 (1.1) 0 0 (0.0) 0 0 (0.0)
General/systemic disorder and administration-site conditions 1 1 (1.1) 0 0 (0.0) 0 0 (0.0)
 Discomfort 1 1 (1.1) 0 0 (0.0) 0 0 (0.0)
Infection and parasitic disease 1 1 (1.1) 0 0 (0.0) 0 0 (0.0)
 Skin infection 1 1 (1.1) 0 0 (0.0) 0 0 (0.0)